city New Delhi India Britain covid-19 Merck Manufacturing city New Delhi India Britain

Sun Pharma gears up to launch Merck's Covid pill under brand name Molxvir in India

Reading now: 504
www.livemint.com

New Delhi: Sun Pharmaceutical Industries on Thursday said it is gearing up to introduce Merck Sharp Dohme (MSD) and Ridgeback's molnupiravir pill, used for the treatment of Covid-19, under the brand name ‘Molxvir’ in India.

The Drugs Controller General of India (DCGI) is currently reviewing clinical data of molnupiravir for the treatment of COVID-19 in adults in India.

Earlier this year, Sun Pharma had signed a non-exclusive voluntary licensing agreement with MSD to manufacture and supply molnupiravir in India and to over 100 low- and middle-income countries.

Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate COVID-19 in adults.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA